Replies to post #183631 on Anavex Life Sciences Corp (AVXL)

[jimmy667]

Muscarinic receptor is listed first. Where have I heard that before? Oh yes the Muscinic receptor drug platform licenced from Heptares by Allegan for a ultimate value of $3.5 billion plus royalties.
So remind me why the rumour of $3.25 billion offer by Biogen and counter of $7..50 by Anavex. Is that out of line given the Allegan/Heptares LICENCE only deal? There was only Phase One data on the Heptares drug. Allergan explained it as the Muscinic receptor activity was highly selective.
But get this: A2-73 concomitantly activates M-1 and Sigma One.